Difference between revisions of "Tang B, et al. Int. J. Cancer (2018) cited as Ref 270 in DOI: 10.1038/s41392-020-0110-5 (Q9533)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: First Author string (P149): Tang B, #quickstatements; #temporary_batch_1589996169159)
(‎Created claim: Page(s) (P105): 109-120, #quickstatements; #temporary_batch_1590074839150)
 
(6 intermediate revisions by the same user not shown)
Property / DOI Identifier
 +
Property / DOI Identifier: 10.1002/ijc.31041 / rank
 +
Normal rank
Property / PubMed ID
 +
Property / PubMed ID: 28905994 / rank
 +
Normal rank
Property / Publication Date
 +
2018
Timestamp+2018-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2018 / rank
 +
Normal rank
Property / Published In Name String
 +
Int. J. Cancer
Property / Published In Name String: Int. J. Cancer / rank
 +
Normal rank
Property / Volume
 +
142
Property / Volume: 142 / rank
 +
Normal rank
Property / title
 +
MicroRNA-324-5p regulates stemness pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling (English)
Property / title: MicroRNA-324-5p regulates stemness pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling (English) / rank
 +
Normal rank
Property / Page(s)
 +
109-120
Property / Page(s): 109-120 / rank
 +
Normal rank

Latest revision as of 15:36, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Tang B, et al. Int. J. Cancer (2018) cited as Ref 270 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Tang B
    0 references
    0 references
    2018
    0 references
    Int. J. Cancer
    0 references
    142
    0 references
    MicroRNA-324-5p regulates stemness pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling (English)
    0 references
    109-120
    0 references